MedTrace Logo

Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period

NCT02032056 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-08

No results posted yet for this study

Summary

The aim of the intervention is to examine the effect of the bacterial strain BB-12, provided for 6 mo, on the prevalence of infections and allergic manifestations in small children, and how BB-12 affects the immune system, the gastrointestinal tract and the microbiota. Children are enrolled during 2 winter seasons.

Conditions

  • Days Absent From Day Care
  • Respiratory Tract Infections
  • Gastrointestinal Infections
  • Allergy

Interventions

DIETARY_SUPPLEMENT

Probiotic (10^9 CFU/day)

DIETARY_SUPPLEMENT

Probiotic (10^8 CFU/day)

OTHER

Placebo

Sponsors & Collaborators

  • The Danish Council for Strategic Research

    collaborator OTHER

  • Chr Hansen

    collaborator INDUSTRY

  • Technical University of Denmark

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Statens Serum Institut

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Months
Max Age
13 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032056 on ClinicalTrials.gov